Detalles de la búsqueda
1.
Low neutralization capacity against SARS-CoV-2 Omicron BQ.1.1 of convalescent plasma collected during circulation of Omicron BA.1.
Vox Sang
; 118(5): 407-408, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36897221
2.
In vitro evaluation of therapeutic antibodies against a SARS-CoV-2 Omicron B.1.1.529 isolate
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-474639
3.
Evaluation of heating and chemical protocols for inactivating SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-036855
4.
In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-023846
5.
Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the UK B.1.1.7 and SA B.1.351 variant
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-441457
6.
Replicative fitness SARS-CoV-2 20I/501Y.V1 variant in a human reconstituted bronchial epithelium
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-436427
7.
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-386904
8.
Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-098731
9.
SARS-CoV-2 20I/501Y.V1 variant in the hamster model
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-440435
10.
Favipiravir and severe acute respiratory syndrome coronavirus 2 in hamster model
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-191775
11.
Pre-clinical evaluation of antiviral activity of nitazoxanide against Sars-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-473113
12.
Biosynthetic proteins targeting the SARS-CoV-2 spike as anti-virals
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-491295
Resultados
1 -
12
de 12
1
Próxima >
>>